SCHEMBL9927436

SCHEMBL9927436

NCCCCCCNS(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.68
CYP1A2 P05177 3/20 0.68
CYP3A4 P08684 3/20 0.68
CYP2C9 P11712 3/20 0.68
CYP2C19 P33261 3/20 0.68
CYP2D6 P10635 2/20 0.68
MEN1 O00255 1/20 0.68
TP53 P04637 1/20 0.68
KMT2A Q03164 1/20 0.68
NPY1R P25929 1/20 0.67
NPY5R Q15761 1/20 0.67
TPSAB1 Q15661 2/20 0.58
SCN1A P35498 2/20 0.58
SCN2A Q99250 2/20 0.58
SCN3A Q9NY46 2/20 0.58
KDM4E B2RXH2 1/20 0.58
HSD17B10 Q99714 1/20 0.58
POLB P06746 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6863251 0.99 ALDH1A1 (0.67) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1928807 0.98 CYP1A2 (0.67) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL1846589 0.97 CYP1A2 (0.66) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL6791530 0.94 ALDH1A1 (0.68) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL14516830 0.90 NPY1R (0.67) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL6370836 0.88 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9942078 0.85 NPY1R (0.67) ALDH1A1NPY1RNPY5RPOLB
SCHEMBL7965887 0.84 TPSAB1 (0.69) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL12085542 0.84 NPY1R (0.58) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL30390387 0.84 ALDH1A1 (0.66) ALDH1A1NPY1RNPY5RPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034798-B2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions CAPROTEC BIOANALYTICS GMBH (DE) 2015-05-19 US disclosed
US-8569481-B2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions PHARMACEUTICALS, INC. (US) 2013-10-29 US disclosed
US-20120148604-A1 TRP INHIBITORS AND USES THEREOF TRANSPOSAGEN BIOPHARMACEUTICALS, INC. (US) 2012-06-14 US disclosed
US-20110118136-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions KOESTER HUBERT 2011-05-19 US disclosed
US-7858560-B2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions CAPROTEC BIOANALYTICS GMBH (DE) 2010-12-28 US disclosed
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions HK PHARMACEUTICALS, INC. 2010-11-25 US disclosed
US-20100248264-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions HK PHARMACEUTICALS, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118136-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions PTMS, QPCTL, SRMS ALDH1A1 4360/4885CYP1A2 4732/4885CYP3A4 3746/4885
US-20120148604-A1 TRP INHIBITORS AND USES THEREOF TRPC4, TRPC1, TRPC3 ALDH1A1 4359/4885CYP1A2 4862/4885CYP3A4 4842/4885
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions CHLSN, PTMS, SRMS ALDH1A1 4064/4885CYP1A2 4648/4885CYP3A4 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.